Documentary AreaSimply the best Documentaries

Michael Moore’s documentary sets out to investigate the highly profitable American health care industry, compares it to other nations and shows HMO horror stories. Sticking to his tried-and-true one-man approach, Moore sheds light on the complicated medical affairs of individuals and local communities. Sicko is as indicting as the rest of Moore’s films.

At a powderkeg moment in American policing, 'The Force' goes deep inside the embattled Oakland Police Department as it struggles to reform itself amid growing local controversy. Filmmaker Peter Nicks embedded with the department over the course of two years to follow its serial efforts to recast itself. The film focuses on the new chief brought in to effect reform at the very moment the Black Lives Matter movement emerges to demand police accountability and racial justice both in Oakland and across the nation.
'The Force' goes inside an embattled urban police department struggling to rebuild trust in one of America's most violent yet promising cities.

A deep historical look at one of the most controversial issues of our time, highlighting the abortion debate from various points along the ideological spectrum in a winding story of abortion in America. 47 years after it revolutionized abortion law in America, the landmark 1973 US Supreme Court case Roe v. Wade is once again at a crossroads. Reversing Roe depicts the state of abortion and women’s rights in America.

In Canada, maple syrup is worth more than oil. When $20 million of syrup goes missing, the trail leads back to an epic battle between cartels and the little guy.

For decades, HSBC, one of the world's largest banks, laundered hundreds of millions of dollars for Mexican drug cartels. Senator Elizabeth Warren, dogged journalists and prosecutors try to hold the bankers to account.

Valeant Pharmaceuticals was a multinational specialty pharmaceutical company based in Canada. It grew rapidly through a series of mergers and acquisitions under the leadership of J. Michael Pearson. The company was involved in a number of controversies surrounding drug price hikes and the use of a specialty pharmacy for the distribution of its drugs, which led to an investigation by the U.S. Securities and Exchange Commission and caused its stock price to plummet more than 90 percent from its peak while its debt surpassed $30 billion.
Wall Street short-sellers exposed a scam that regulators overlook: how Big Pharma gouges patients in need of life-saving drugs.